V de Haas
Overview
Explore the profile of V de Haas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
711
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Segerink W, de Haas V, Kaspers G
Expert Rev Anticancer Ther
. 2021 Mar;
21(4):451-459.
PMID: 33706635
: A systematic review was performed to assess the prognostic value of Measurable Residual Disease (MRD) during treatment, for relapse and overall survival in pediatric acute myeloid leukemia (AML).: A...
2.
Sassen S, Mathot R, Pieters R, de Haas V, Kaspers G, van den Bos C, et al.
Clin Infect Dis
. 2019 Dec;
71(8):e281-e288.
PMID: 31790556
Background: Ciprofloxacin is used as antimicrobial prophylaxis in pediatric acute lymphoblastic leukemia (ALL) to decrease infections with gram-negative bacteria. However, there are no clear guidelines concerning prophylactic dose. Aims: To...
3.
Reedijk A, Klein K, Coebergh J, Kremer L, Dinmohamed A, de Haas V, et al.
Leukemia
. 2018 Dec;
33(6):1349-1359.
PMID: 30568171
Variation in survival of pediatric acute myeloid leukemia (pAML) over time and between Western European countries exists. The aim of the current study is to assess the progress made for...
4.
Jerchel I, Hoogkamer A, Aries I, Steeghs E, Boer J, Besselink N, et al.
Leukemia
. 2017 Oct;
32(4):931-940.
PMID: 28972594
RAS pathway mutations have been linked to relapse and chemotherapy resistance in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, comprehensive data on the frequency and prognostic value of subclonal...
5.
Larmonie N, Arentsen-Peters T, Obulkasim A, Valerio D, Sonneveld E, Danen-van Oorschot A, et al.
Oncogene
. 2017 Sep;
37(1):107-115.
PMID: 28892045
In acute myeloid leukemia (AML), specific genomic aberrations induce aberrant methylation, thus directly influencing the transcriptional programing of leukemic cells. Therefore, therapies targeting epigenetic processes are advocated as a promising...
6.
Emmrich S, Engeland F, El-Khatib M, Henke K, Obulkasim A, Schoning J, et al.
Oncogene
. 2015 Jul;
35(14):1822-31.
PMID: 26165837
MicroRNAs (miRNAs) are crucial components of homeostatic and developmental gene regulation. In turn, dysregulation of miRNA expression is a common feature of different types of cancer, which can be harnessed...
7.
Calkoen F, Vervat C, van Pel M, de Haas V, Vijfhuizen L, Eising E, et al.
Stem Cell Res
. 2015 Feb;
14(2):198-210.
PMID: 25679997
Pediatric myelodysplastic syndrome (MDS) is a heterogeneous disease covering a spectrum ranging from aplasia (RCC) to myeloproliferation (RAEB(t)). In adult-type MDS there is increasing evidence for abnormal function of the...
8.
Thiry J, Gonzalez-Martin J, Elvira L, Pagot E, Voisin F, Lequeux G, et al.
Vet Rec
. 2014 Mar;
174(17):430.
PMID: 24603464
The efficacy and safety of a florfenicol plus flunixin meglumine formulation in the treatment of respiratory disease was evaluated in calves less than six weeks of age, compared with a...
9.
Coenen E, Zwaan C, Stary J, Baruchel A, de Haas V, Stam R, et al.
Leukemia
. 2014 Feb;
28(7):1564-8.
PMID: 24561520
No abstract available.
10.
Emmrich S, Katsman-Kuipers J, Henke K, Khatib M, Jammal R, Engeland F, et al.
Leukemia
. 2013 Nov;
28(5):1022-32.
PMID: 24270738
MicroRNAs (miRNAs) play a pivotal role in the regulation of hematopoiesis and development of leukemia. Great interest emerged in modulating miRNA expression for therapeutic purposes. In order to identify miRNAs,...